Telix Pharmaceuticals Lim... (TLPPF)

PNK: TLPPF · Real-Time Price · USD

17.87

0.75 (4.38%)

At close: May 01, 2025, 1:25 PM

Telix Pharmaceuticals Cash Flow Statement

Financials in AUD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	n/a	5.21M	-104.08M	-80.51M	-44.89M	-27.87M	-13.83M	-6.38M	-44K
Depreciation & Amortization	n/a	6.92M	5.38M	5.17M	4.88M	4.24M	6.97K	3.79K	n/a
Stock-Based Compensation	n/a	8.79M	8.11M	1.32M	2.35M	1.27M	712K	109.02K	n/a
Other Working Capital	n/a	-57.53M	-6.5M	-101K	30.56M	198K	-1.48M	-551.42K	n/a
Other Non-Cash Items	n/a	60.5M	41M	31.52M	18.66M	9.69M	13.82M	-1	44K
Deferred Income Tax	n/a	n/a	-13.38M	-14.2M	-10.86M	-10.3M	-17.19M	-6.37M	n/a
Change in Working Capital	n/a	-57.53M	-1.01M	-2.63M	31.81M	-361K	-4.27M	232.79K	n/a
Operating Cash Flow	n/a	23.88M	-63.97M	-59.33M	1.96M	-23.33M	-20.75M	-6.03M	n/a
Capital Expenditures	-34.03M	-10.79M	-13.86M	-1.34M	-322K	-468K	n/a	-5.64K	n/a
Cash Acquisitions	-34.69M	n/a	-973K	n/a	-322K	n/a	-2.69M	4.38K	n/a
Purchase of Investments	-51.99M	-13.15M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-34.17M	-2.65M	-2.16M	-1.39M	-447K	-65K	n/a	n/a	n/a
Investing Cash Flow	-135.17M	-25.49M	-17M	-2.73M	-1.09M	-468K	-2.69M	-1.26K	n/a
Debt Repayment	652.81M	5.76M	3M	-340K	-402K	-943K	-869.35K	-769.18K	n/a
Common Stock Repurchased	n/a	n/a	-7.82M	n/a	-130K	n/a	n/a	-2.99M	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-54.79M	n/a
Other Financial Acitivies	-14.88M	-2.22M	-1.26M	-596K	-502K	-1.59M	n/a	n/a	n/a
Financial Cash Flow	638.92M	10.19M	174.96M	2.85M	34.12M	42.72M	-869.35K	54.79M	n/a
Net Cash Flow	587.11M	6.91M	94.29M	-55.91M	33.35M	18.83M	-22.99M	54.79M	n/a
Free Cash Flow	9M	13.09M	-77.83M	-60.67M	1.64M	-23.8M	-20.75M	-6.04M	n/a